Paulina Cruz, MD

Insulin is generally recommended as a second-line therapy when non-insulin agents alone or in combination at maximal tolerated doses fail to achieve glucose targets within a 3 to 6 month period.

Insulin is generally recommended as a second-line therapy when non-insulin agents alone or in combination at maximal tolerated doses fail to achieve glucose targets within a 3 to 6 month period.